Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to VenetoclaxJoan Montero, Andrew A. Lane, Jason Stephansky et al.|Cancer Discovery|2016Cited by 209
Review on organic phase change materials for sustainable energy storageAoshuang Yang, Wenbin Yang, Yuanlin Zhou et al.|Sustainable Energy & Fuels|2022Cited by 48
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Marina Konopleva, Nathaniel R. Wilson et al.|Leukemia Research|2022Cited by 18